Aus Bio Ltd. is a public but unlisted, Melbourne based biotechnology research and development company (R&D). Principal objectives are:
Wednesday 18 November 2020
11:00 AM AEDT
AGM Presentation.Read More
Result of Annual General Meeting (ASX Report).Read More
Full signed financial statements (financial year 2020).Read More
On behalf of your board we are pleased to present the 2020 Review of Operations, Scientific Advisory Panel and Corporate Governance Statements.Read More
Melbourne, Australia; 5 March 2020.
A newly formed biopharmaceutical company AusVir Therapeutics Pty Ltd, focused on the development and commercialization of novel medicines targeting viral infection, today announced that it has raised AUD$23 million in a Series A financing led by Morningside Venture Investments.
“New Drugs are Coming to Fight Nasty Flu Seasons”Read More
Aus Bio’s MD2009 project has resulted in the pre-clinical development of a number of antiviral drug candidates which have a different mode of action to the currently used neuraminidase inhibitors.Read More
Aus Bio’s Respiratory Project – MD990 – has resulted from the identification of several specific carbohydrates, which have been shown to influence and enhance recovery of injured human respiratory cells.Read More